Nguyen Tran
Insider CIK 1457013 · DNAI Director · SOMX SVP and CFO · PRTA See Remarks · RAIN Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| PRTA PROTHENA CORP PUBLIC LTD C | M Exercise deriv | 2026-07-28 | 2026-07-30 | 57,000 | — | $0 | 0 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | D To issuer | 2026-07-28 | 2026-07-30 | 57,000 | $8.56 | $487.9K | 40,205 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | M Exercise | 2026-07-28 | 2026-07-30 | 57,000 | — | $0 | 97,205 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | M Exercise deriv | 2026-07-28 | 2026-07-30 | 57,000 | — | $0 | 0 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | D To issuer | 2026-07-28 | 2026-07-30 | 57,000 | $8.56 | $487.9K | 40,205 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | M Exercise | 2026-07-28 | 2026-07-30 | 57,000 | — | — | 97,205 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | A Award deriv | 2026-03-03 | 2026-03-05 | 230,000 | — | $0 | 230,000 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | A Award | 2025-07-28 | 2025-07-30 | 95,000 | — | $0 | 97,205 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | A Award deriv | 2025-03-05 | 2025-03-07 | 107,500 | — | $0 | 107,500 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | A Award deriv | 2024-02-27 | 2024-02-29 | 85,000 | — | $0 | 85,000 | SEC↗ |
| RAIN Rain Oncology Inc. | D To issuer deriv | 2024-01-26 | 2024-01-26 | 20,000 | — | $0 | 0 | SEC↗ |
| RAIN Rain Oncology Inc. | D To issuer deriv | 2024-01-26 | 2024-01-26 | 35,000 | — | $0 | 0 | SEC↗ |
| RAIN Rain Oncology Inc. | D To issuer deriv | 2024-01-26 | 2024-01-26 | 13,890 | — | $0 | 0 | SEC↗ |
| RAIN Rain Oncology Inc. | D To issuer deriv | 2024-01-26 | 2024-01-26 | 42,596 | — | $0 | 0 | SEC↗ |
| RAIN Rain Oncology Inc. | A Award deriv | 2023-08-09 | 2023-08-11 | 35,000 | — | $0 | 35,000 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | M Exercise deriv | 2023-05-17 | 2023-05-17 | 50,000 | — | $0 | 0 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | M Exercise deriv | 2023-05-17 | 2023-05-17 | 45,000 | — | $0 | 0 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | S Sale | 2023-05-17 | 2023-05-17 | 9,215 | $75.44 | $695.2K | 3,300 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | S Sale | 2023-05-17 | 2023-05-17 | 37,044 | $74.55 | $2.76M | 12,515 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | S Sale | 2023-05-17 | 2023-05-17 | 34,640 | $73.54 | $2.55M | 49,559 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | S Sale | 2023-05-17 | 2023-05-17 | 100 | $76.04 | $7.6K | 3,200 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | S Sale | 2023-05-17 | 2023-05-17 | 14,001 | $72.66 | $1.02M | 84,199 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | M Exercise | 2023-05-17 | 2023-05-17 | 45,000 | $29.81 | $1.34M | 48,200 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | M Exercise | 2023-05-17 | 2023-05-17 | 50,000 | $22.85 | $1.14M | 98,200 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | M Exercise deriv | 2023-03-15 | 2023-03-17 | 10,000 | — | $0 | 0 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | S Sale | 2023-03-15 | 2023-03-17 | 4,802 | $48.16 | $231.3K | 8,398 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | S Sale | 2023-03-15 | 2023-03-17 | 5,198 | $48.68 | $253.0K | 3,200 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | M Exercise | 2023-03-15 | 2023-03-17 | 10,000 | $6.73 | $67.3K | 13,200 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | A Award deriv | 2023-03-02 | 2023-03-03 | 48,000 | — | $0 | 48,000 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | M Exercise deriv | 2023-02-15 | 2023-02-17 | 10,000 | — | $0 | 10,000 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | S Sale | 2023-02-15 | 2023-02-17 | 9,336 | $53.30 | $497.6K | 3,864 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | S Sale | 2023-02-15 | 2023-02-17 | 664 | $53.87 | $35.8K | 3,200 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | M Exercise | 2023-02-15 | 2023-02-17 | 10,000 | $6.73 | $67.3K | 13,200 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | M Exercise deriv | 2023-01-18 | 2023-01-20 | 10,000 | — | $0 | 20,000 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | M Exercise | 2023-01-18 | 2023-01-20 | 10,000 | $6.73 | $67.3K | 13,200 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | S Sale | 2023-01-18 | 2023-01-20 | 638 | $56.97 | $36.3K | 3,200 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | S Sale | 2023-01-18 | 2023-01-20 | 2,085 | $56.32 | $117.4K | 3,838 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | S Sale | 2023-01-18 | 2023-01-20 | 7,277 | $55.18 | $401.5K | 5,923 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | M Exercise deriv | 2022-12-21 | 2022-12-23 | 10,000 | — | $0 | 30,000 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | M Exercise | 2022-12-21 | 2022-12-23 | 10,000 | $6.73 | $67.3K | 13,200 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | S Sale | 2022-12-21 | 2022-12-23 | 3,155 | $58.46 | $184.4K | 10,045 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | S Sale | 2022-12-21 | 2022-12-23 | 6,845 | $59.21 | $405.3K | 3,200 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | M Exercise deriv | 2022-11-23 | 2022-11-25 | 10,000 | — | $0 | 40,000 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | M Exercise | 2022-11-23 | 2022-11-25 | 10,000 | $6.73 | $67.3K | 13,200 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | S Sale | 2022-11-23 | 2022-11-25 | 3,984 | $61.28 | $244.1K | 4,669 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | S Sale | 2022-11-23 | 2022-11-25 | 1,469 | $62.28 | $91.5K | 3,200 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | S Sale | 2022-11-23 | 2022-11-25 | 4,547 | $60.53 | $275.2K | 8,653 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | M Exercise deriv | 2022-10-19 | 2022-10-21 | 10,000 | — | $0 | 50,000 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | M Exercise | 2022-10-19 | 2022-10-21 | 10,000 | $6.73 | $67.3K | 13,200 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | S Sale | 2022-10-19 | 2022-10-21 | 2,768 | $55.04 | $152.4K | 10,432 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | S Sale | 2022-10-19 | 2022-10-21 | 171 | $58.17 | $9.9K | 3,200 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | S Sale | 2022-10-19 | 2022-10-21 | 4,541 | $57.30 | $260.2K | 3,371 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | S Sale | 2022-10-19 | 2022-10-21 | 2,520 | $56.30 | $141.9K | 7,912 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | M Exercise deriv | 2022-09-21 | 2022-09-23 | 10,000 | — | $0 | 60,000 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | S Sale | 2022-09-21 | 2022-09-23 | 10,000 | $30.75 | $307.5K | 3,200 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | M Exercise | 2022-09-21 | 2022-09-23 | 10,000 | $6.73 | $67.3K | 13,200 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | M Exercise deriv | 2022-08-24 | 2022-08-26 | 10,000 | — | $0 | 70,000 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | M Exercise | 2022-08-24 | 2022-08-26 | 10,000 | $6.73 | $67.3K | 13,200 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | S Sale | 2022-08-24 | 2022-08-26 | 10,000 | $30.17 | $301.7K | 3,200 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | M Exercise deriv | 2022-07-22 | 2022-07-22 | 7,320 | — | $0 | 80,000 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | M Exercise | 2022-07-22 | 2022-07-22 | 7,320 | $6.73 | $49.3K | 10,520 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | S Sale | 2022-07-22 | 2022-07-22 | 7,320 | $32.55 | $238.3K | 3,200 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | M Exercise deriv | 2022-07-21 | 2022-07-22 | 20,560 | — | $0 | 87,320 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | M Exercise | 2022-07-21 | 2022-07-22 | 20,560 | $6.73 | $138.4K | 23,760 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | S Sale | 2022-07-21 | 2022-07-22 | 20,555 | $32.64 | $670.9K | 3,205 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | S Sale | 2022-07-21 | 2022-07-22 | 5 | $33.69 | $168 | 3,200 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | M Exercise deriv | 2022-07-20 | 2022-07-22 | 42,120 | — | $0 | 107,880 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | S Sale | 2022-07-20 | 2022-07-22 | 16,984 | $32.73 | $555.9K | 3,200 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | M Exercise | 2022-07-20 | 2022-07-22 | 42,120 | $6.73 | $283.5K | 45,320 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | S Sale | 2022-07-20 | 2022-07-22 | 25,136 | $32.32 | $812.4K | 20,184 | SEC↗ |
| RAIN Rain Therapeutics Inc. | A Award deriv | 2022-06-01 | 2022-08-19 | 20,000 | — | $0 | 20,000 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | A Award deriv | 2022-02-23 | 2022-02-25 | 85,000 | — | $0 | 85,000 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | A Award deriv | 2021-02-25 | 2021-02-26 | 84,000 | — | $0 | 84,000 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | A Award deriv | 2021-02-12 | 2021-02-17 | 40,625 | — | $0 | 40,625 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | A Award deriv | 2021-02-12 | 2021-02-17 | 60,150 | — | $0 | 60,150 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | D To issuer deriv | 2021-02-12 | 2021-02-17 | 55,000 | — | $0 | 0 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | D To issuer deriv | 2021-02-12 | 2021-02-17 | 80,000 | — | $0 | 0 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | A Award deriv | 2021-02-12 | 2021-02-17 | 39,062 | — | $0 | 39,062 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | D To issuer deriv | 2021-02-12 | 2021-02-17 | 75,000 | — | $0 | 0 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | D To issuer deriv | 2021-02-12 | 2021-02-17 | 65,000 | — | $0 | 0 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | A Award deriv | 2021-02-12 | 2021-02-17 | 50,000 | — | $0 | 50,000 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | J Other | 2020-04-08 | 2025-02-14 | 995 | — | $0 | 2,205 | SEC↗ |
| PRTA Prothena Corp plc | A Award deriv | 2020-02-25 | 2020-02-27 | 105,000 | — | $0 | 105,000 | SEC↗ |
| SRRA Sierra Oncology, Inc. | A Award deriv | 2019-06-11 | 2019-06-12 | 30,000 | — | $0 | 30,000 | SEC↗ |
| PRTA Prothena Corp plc | A Award deriv | 2019-02-27 | 2019-03-01 | 95,000 | — | $0 | 95,000 | SEC↗ |
| PRTA Prothena Corp plc | A Award deriv | 2018-06-21 | 2018-06-25 | 250,000 | — | $0 | 250,000 | SEC↗ |
| SRRA Sierra Oncology, Inc. | A Award deriv | 2018-06-12 | 2018-06-14 | 25,000 | — | $0 | 25,000 | SEC↗ |
| PRTA Prothena Corp plc | A Award deriv | 2018-02-21 | 2018-02-23 | 80,000 | — | $0 | 80,000 | SEC↗ |
| SRRA Sierra Oncology, Inc. | A Award deriv | 2017-06-13 | 2017-06-14 | 25,000 | — | $0 | 25,000 | SEC↗ |
| PRTA Prothena Corp plc | P Buy | 2017-03-09 | 2017-03-09 | 1,000 | $51.32 | $51.3K | 3,200 | SEC↗ |
| PRTA Prothena Corp plc | A Award deriv | 2017-02-22 | 2017-02-24 | 75,000 | — | $0 | 75,000 | SEC↗ |
| DNAI ProNAi Therapeutics Inc | A Award deriv | 2016-06-09 | 2016-06-13 | 77,670 | — | $0 | 77,670 | SEC↗ |
| PRTA Prothena Corp plc | A Award deriv | 2016-02-24 | 2016-02-26 | 65,000 | — | $0 | 65,000 | SEC↗ |
| PRTA Prothena Corp plc | M Exercise deriv | 2015-12-09 | 2015-12-11 | 30,000 | — | $0 | 150,000 | SEC↗ |
| PRTA Prothena Corp plc | S Sale | 2015-12-09 | 2015-12-11 | 19,731 | $66.37 | $1.31M | 4,300 | SEC↗ |
| PRTA Prothena Corp plc | M Exercise | 2015-12-09 | 2015-12-11 | 30,000 | $6.73 | $201.9K | 32,200 | SEC↗ |
| PRTA Prothena Corp plc | S Sale | 2015-12-09 | 2015-12-11 | 8,169 | $65.46 | $534.7K | 24,031 | SEC↗ |
| PRTA Prothena Corp plc | S Sale | 2015-12-09 | 2015-12-11 | 2,100 | $67.00 | $140.7K | 2,200 | SEC↗ |
| PRTA Prothena Corp plc | A Award deriv | 2015-03-11 | 2015-03-12 | 55,000 | — | $0 | 55,000 | SEC↗ |
| PRTA Prothena Corp plc | P Buy | 2014-05-09 | 2014-05-12 | 2,200 | $19.61 | $43.1K | 2,200 | SEC↗ |
| PRTA Prothena Corp plc | A Award deriv | 2014-02-04 | 2014-02-06 | 45,000 | — | $0 | 45,000 | SEC↗ |
| PRTA Prothena Corp plc | A Award deriv | 2013-04-01 | 2013-04-02 | 180,000 | — | $0 | 180,000 | SEC↗ |
| SOMX Pernix Sleep, Inc. | D To issuer | 2013-03-06 | 2013-03-08 | 42,419 | — | $0 | 0 | SEC↗ |
| SOMX Somaxon Pharmaceuticals, I | S Sale | 2013-01-02 | 2013-01-03 | 412 | $3.08 | $1.3K | 49,949 | SEC↗ |
| SOMX Somaxon Pharmaceuticals, I | A Award | 2012-12-31 | 2013-01-03 | 1,494 | — | $0 | 50,361 | SEC↗ |
| SOMX Somaxon Pharmaceuticals, I | A Award | 2012-11-16 | 2012-11-20 | 30,000 | — | $0 | 52,617 | SEC↗ |
| SOMX Somaxon Pharmaceuticals, I | A Award | 2012-09-30 | 2012-10-02 | 15,716 | — | $0 | 150,941 | SEC↗ |
| SOMX Somaxon Pharmaceuticals, I | A Award | 2012-07-02 | 2012-07-03 | 15,992 | — | $0 | 135,225 | SEC↗ |
| SOMX Somaxon Pharmaceuticals, I | S Sale | 2012-01-03 | 2012-01-04 | 3,300 | $0.48 | $1.6K | 119,233 | SEC↗ |